• Home
  • Search
  • SALL4 Is Required for YAP1-Dependent Malignant and Regenerative Hepatocyte-to-Cholangiocyte Reprogramming
  • Cite Icon1
  • https://doi.org/10.1158/2767-9764.crc-25-0172Copy DOI Icon

SALL4 Is Required for YAP1-Dependent Malignant and Regenerative Hepatocyte-to-Cholangiocyte Reprogramming

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Hepatocytes (HC), which share a developmental origin with cholangiocytes (CC), have the capacity to undergo reparative reprogramming into CCs in response to liver injury and, under specific conditions, can also transform malignantly into cholangiocarcinoma (CCA). However, the molecular mechanisms governing HC plasticity in liver diseases remain poorly understood. In this study, we investigated the role of spalt-like transcription factor 4 (SALL4), an oncofetal transcription factor, in both malignant and regenerative HC fate transitions toward the biliary lineage. Using Sleeping Beauty hydrodynamic tail vein injection–mediated murine liver cancer models, we explored HC-to-CCA transformation, whereas the 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet–induced cholestasis model was used to investigate regenerative HC-to-CC reprogramming. Our findings reveal that SALL4 is specifically required for myristoylated Akt–YAP1S127A-driven HC-to-CCA transformation, as its loss significantly suppressed malignant reprogramming and clonal expansion. Surprisingly, Sall4 overexpression also prevented YAP1S127A-driven CCA development while promoting the expansion of liver progenitor cell (LPC)-like fatty HCs. Mechanistically, we propose Bmi1 as a key downstream effector of SALL4 in YAP1-dependent HC-to-CCA transformation. Additionally, in the DDC–fed cholestasis model, Sall4 deletion enhanced HC-to-LPC activation while impairing LPC differentiation into mature CCs. These findings establish SALL4 as a critical regulator of HC plasticity in both malignant and regednerative contexts and highlight its potential as a therapeutic target for specific liver cancer subtypes.Significance:HC plasticity supports repair but can drive malignancy, acting as a double-edged sword. We identify SALL4 as regulator of YAP1-driven HC-to-CC reprogramming, revealing the YAP1–SALL4–BMI1 axis as a therapeutic target for CCA.

Similar Papers
  • Research Article
  • Citations11

Normal Liver Progenitor Cells in Culture

  • Jan 01, 2004
  • Katherine S Koch +1
  • Preprint Article

Data from Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer–Initiating Cells

  • Mar 31, 2023
  • Miaoling Tang +12
  • Research Article
  • Citations32

Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member γ, but not α or δ

  • May 25, 2005
  • Carcinogenesis
  • Belinda Knight +3
  • Research Article
  • Citations6

Integrated analysis of multiple transcriptomic data identifies ST8SIA6‑AS1 and LINC01093 as potential biomarkers in HBV‑associated liver cancer

  • Mar 24, 2023
  • Oncology Letters
  • Jianhua Xue +4
  • Research Article

Transfer RNA-Derived Small RNAs (tsRNAs): A New Insight into Liver Cancer

  • Jan 01, 2024
  • ASEAN Journal of Psychiatry
  • Zixuan Zhang +3
  • Research Article

TCF12 enhances angiogenesis and affects sorafenib response in liver cancer via HIF-1α interaction

  • Apr 04, 2025
  • Biomolecules and Biomedicine
  • Yuanbin Chen +6
  • PDF
  • Research Article
  • Citations12

Gold Nanosystems Covered with Doxorubicin/DNA Complexes: A Therapeutic Target for Prostate and Liver Cancer

  • Dec 08, 2022
  • International Journal of Molecular Sciences
  • Rosa M Giráldez-Pérez +6
  • Research Article
  • Citations24

Tropomodulin3 promotes liver cancer progression by activating the MAPK/ERK signaling pathway.

  • Mar 07, 2019
  • Oncology reports
  • Canguang Jin +3
  • Book Chapter
  • Citations12

Human liver growth and development

  • Jan 01, 1998
  • Tania Roskams +2
  • Research Article
  • Citations1

Abstract C61: GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN

  • Oct 01, 2013
  • Cancer Research
  • Wan-Ting Chen +5
  • Front Matter
  • Citations26

The potential of CXCL5 as a target for liver cancer – what do we know so far?

  • Dec 11, 2014
  • Expert Opinion on Therapeutic Targets
  • Jinglin Xia +4
  • PDF
  • Research Article
  • Citations9

CD24+LCN2+ liver progenitor cells in ductular reaction contributed to macrophage inflammatory responses in chronic liver injury

  • Oct 02, 2023
  • Cell & Bioscience
  • Wei-Jian Huang +18
  • Research Article
  • Citations12

Knockdown of hsa_circ_0102231 Impedes the Progression of Liver Cancer through the miR-873-SOX4 Axis.

  • Feb 01, 2025
  • Current gene therapy
  • Jingyu Qian +3
  • Research Article

Expression and biological role of the neutral cholesterol ester hydrolase 1 gene in liver cancer tissue and cell lines

  • Aug 16, 2021
  • DOAJ (DOAJ: Directory of Open Access Journals)
  • Yanwei Zeng +3
  • Research Article
  • Citations98

MiR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.

  • Apr 30, 2015
  • Cancer Research
  • Jing Zhang +10
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.